This Decision applies to the biocidal product family identified by the case number BC-LR019221-36 in the Register for Biocidal Products.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Commission Implementing Decision (EU) 2019/641 of 17 April 2019 on the terms and conditions of the authorisation of a biocidal product family containing 1R-trans phenothrin referred by Ireland in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2019) 2837) (Text with EEA relevance.)
The biocidal product family referred to in Article 1 meets the condition laid down in Article 19(1)(b)(i) of Regulation (EU) No 528/2012.
This Decision is addressed to the Member States.
Cite this act
Commission Implementing Decision (EU) 2019/641 of 17 April 2019 on the terms and conditions of the authorisation of a biocidal product family containing 1R-trans phenothrin referred by Ireland in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2019) 2837) (Text with EEA relevance.) (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32019D0641
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com